Literature DB >> 10921429

Survival of HIV-1 in syringes: effects of temperature during storage.

N Abdala1, R Reyes, J M Carney, R Heimer.   

Abstract

In a previous paper we demonstrated that HIV-1 survival in syringes was strongly associated with the volume of blood remaining and with the duration of storage at room temperature. The current study was performed to determine the effects of storage temperature upon the survival of HIV-1 inside syringes. At 4 degrees C, 50% of all syringes contained viable HIV-1 at 42 days of storage, the longest storage duration tested. At room temperature (20 degrees C), the last day that syringes with 2 microL of infected blood were positive was Day 21, and viable HIV-1 was recovered from 8% of syringes. The last day on which syringes with 20 microL were positive was Day 42, and viable HIV-1 was recovered from 8% of syringes. Above room temperature (27, 32, and 37 degrees C), the likelihood of encountering syringes with viable HIV-1 when periods of storage exceeded 1 week decreased to less than 1%. The temperatures at which drug injectors are likely to store their used syringes will vary according to climate, season, and circumstances faced by the injector. The survival of HIV-1 in contaminated syringes varied over a range of temperatures, and this may be a factor influencing the syringe-borne transmission of HIV-1.

Entities:  

Mesh:

Year:  2000        PMID: 10921429     DOI: 10.3109/10826080009148220

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  12 in total

1.  The beginning of a new era in understanding hepatitis C virus prevention.

Authors:  Josiah D Rich; Lynn E Taylor
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

Review 2.  Update and overview of practical epidemiologic aspects of HIV/AIDS among injection drug users in the United States.

Authors:  Scott S Santibanez; Richard S Garfein; Andrea Swartzendruber; David W Purcell; Lynn A Paxton; Alan E Greenberg
Journal:  J Urban Health       Date:  2006-01       Impact factor: 3.671

3.  Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis.

Authors:  Alexis M Roth; Richard A Armenta; Karla D Wagner; Scott C Roesch; Ricky N Bluthenthal; Jazmine Cuevas-Mota; Richard S Garfein
Journal:  Subst Use Misuse       Date:  2014-10-14       Impact factor: 2.164

4.  Risk factors for hepatitis B in an outbreak of hepatitis B and D among injection drug users.

Authors:  Stephanie R Bialek; William A Bower; Karen Mottram; Dave Purchase; T Nakano; Omana Nainan; Ian T Williams; Beth P Bell
Journal:  J Urban Health       Date:  2005-07-27       Impact factor: 3.671

5.  Recovering Infectious HIV from Novel Syringe-Needle Combinations with Low Dead Space Volumes.

Authors:  Nadia Abdala; Amisha Patel; Robert Heimer
Journal:  AIDS Res Hum Retroviruses       Date:  2016-08-22       Impact factor: 2.205

6.  Needle stick injuries in the community.

Authors: 
Journal:  Paediatr Child Health       Date:  2008-03       Impact factor: 2.253

7.  High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.

Authors:  William A Zule; Georgiy Bobashev
Journal:  Drug Alcohol Depend       Date:  2008-11-11       Impact factor: 4.492

8.  Disinfection of syringes contaminated with hepatitis C virus by rinsing with household products.

Authors:  Mawuena Binka; Elijah Paintsil; Amisha Patel; Brett D Lindenbach; Robert Heimer
Journal:  Open Forum Infect Dis       Date:  2015-02-23       Impact factor: 3.835

9.  Childhood exposures to discarded needles and other objects potentially contaminated with blood-borne pathogens in Toronto, Canada.

Authors:  Faisal Kordy; Astrid Petrich; Stanley E Read; Ari Bitnun
Journal:  Paediatr Child Health       Date:  2017-09-25       Impact factor: 2.253

10.  Robustness promotes evolvability of thermotolerance in an RNA virus.

Authors:  Robert C McBride; C Brandon Ogbunugafor; Paul E Turner
Journal:  BMC Evol Biol       Date:  2008-08-11       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.